SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-038292
Filing Date
2022-11-25
Accepted
2022-11-25 13:07:15
Documents
12
Period of Report
2022-11-22
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K achv-8k_20221122.htm   iXBRL 8-K 32763
  Complete submission text file 0001564590-22-038292.txt   164539

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA achv-20221122.xsd EX-101.SCH 5617
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20221122_lab.xml EX-101.LAB 20041
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20221122_pre.xml EX-101.PRE 11945
6 EXTRACTED XBRL INSTANCE DOCUMENT achv-8k_20221122_htm.xml XML 3674
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 033-80623 | Film No.: 221419455
SIC: 2835 In Vitro & In Vivo Diagnostic Substances